CIVES, MAURO

CIVES, MAURO  

DIPARTIMENTO INTERDISCIPLINARE DI MEDICINA  

Mostra records
Risultati 1 - 20 di 68 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autore(i) File
1101MO Development of CAR T-cells for future treatment of NETs 1-gen-2021 Mandriani, B.; Pelle', E.; Mannavola, F.; Ingravallo, G.; Cazzato, G.; Ramello, M. C.; Porta, C. G.; Strosberg, J. R.; Abate-Daga, D.; Cives, M.
Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives 1-gen-2021 Mandriani, B.; Pelle', E.; Pezzicoli, G.; Strosberg, J.; Abate-Daga, D.; Guarini, A.; Cives, M.; Porta, C.
Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment 1-gen-2021 Lamarca, Angela; Cives, Mauro; de Mestier, Louis; Crona, Joakim; Spada, Francesca; Öberg, Kjell; Pavel, Marianne; Alonso-Gordoa, Teresa
Analysis of Postoperative Recurrence in Stage I-III Midgut Neuroendocrine Tumors 1-gen-2018 Cives, Mauro; Anaya, Daniel A.; Soares, Heloisa; Coppola, Domenico; Strosberg, Jonathan
Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors 1-gen-2016 Cives, Mauro; Ghayouri, M.; Morse, B.; Brelsford, M.; Black, M.; Rizzo, A.; Meeker, A.; Strosberg, J.
Analysis of the immune landscape of small bowel neuroendocrine tumors 1-gen-2019 Cives, M; Strosberg, J; Al Diffalha, S; Coppola, D
Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications 1-gen-2022 Lauricella, Eleonora; Mandriani, Barbara; Cavallo, Federica; Pezzicoli, Gaetano; Chaoul, Nada; Porta, Camillo; Cives, Mauro
Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours 1-gen-2021 Dawod, M.; Gordoa, T. A.; Cives, M.; De Mestier, L.; Crona, J.; Spada, F.; Oberg, K.; Pavel, M.; Lamarca, A.
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 1-gen-2022 Ricci, C.; Pusceddu, S.; Prinzi, N.; Tafuto, S.; Ibrahim, T.; Filice, A.; Brizzi, M. P.; Panzuto, F.; Baldari, S.; Grana, C. M.; Campana, D.; Davi, M. V.; Giuffrida, D.; Zatelli, M. C.; Partelli, S.; Razzore, P.; Marconcini, R.; Massironi, S.; Gelsomino, F.; Faggiano, A.; Giannetta, E.; Bajetta, E.; Grimaldi, F.; Cives, M.; Cirillo, F.; Perfetti, V.; Corti, F.; Ricci, C.; Giacomelli, L.; Porcu, L.; Di Maio, M.; Seregni, E.; Maccauro, M.; Lastoria, S.; Bongiovanni, A.; Versari, A.; Persano, I.; Rinzivillo, M.; Pignata, S. A.; Rocca, P. A.; Lamberti, G.; Cingarlini, S.; Puliafito, I.; Ambrosio, M. R.; Zanata, I.; Bracigliano, A.; Severi, S.; Spada, F.; Andreasi, V.; Modica, R.; Scalorbi, F.; Milione, M.; Sabella, G.; Coppa, J.; Casadei, R.; Di Bartolomeo, M.; Falconi, M.; De Braud, F.
Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe 1-gen-2013 Cives, Mauro; Ciavarella, Sabino; Rizzo, FRANCESCA MARIA; DE MATTEO, Monica; Dammacco, Francesco; Silvestris, Francesco
BONE METASTASES IN NEUROENDOCRINE TUMORS: MOLECULAR PATHOGENESIS AND IMPLICATIONS IN CLINICAL PRACTICE. 1-gen-2020 Cives, M; Pelle', E; Rinzivillo, M; Prosperi, D; Tucci, M; Silvestris, F; Panzuto, F
Cell fusion in myeloma marrow microenvironment: role in tumor progression 1-gen-2013 Cives, Mauro; Ciavarella, S; Dammacco, F; Silvestris, Francesco
Cerebellar ataxia and exercise intolerance in Erdheim-Chester disease 1-gen-2021 Lauricella, E.; D'Amati, A.; Ingravallo, G.; Foresio, M.; Ribatti, D.; de Tommaso, M.; Cives, M.; Girolamo, F.
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours 1-gen-2019 Rizzo, Francesca M; Vesely, Clare; Childs, Alexa; Marafioti, Teresa; Khan, Mohid S; Mandair, Dalvinder; Cives, Mauro; Ensell, Leah; Lowe, Helen; Akarca, Ayse U; Luong, Tuvinh; Caplin, Martyn; Toumpanakis, Christos; Krell, Daniel; Thirlwell, Christina; Silvestris, Franco; Hartley, John A; Meyer, Tim
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors 1-gen-2019 Cives, M.; Partelli, S.; Palmirotta, R.; Lovero, D.; Mandriani, B.; Quaresmini, D.; Pelle', E.; Andreasi, V.; Castelli, P.; Strosberg, J.; Zamboni, G.; Falconi, M.; Silvestris, F.
A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. 1-gen-2016 Oberg, K; Krenning, E; Sundin, A; Bodei, L; Kidd, M; Tesselaar, M; Ambrosini, V; Baum, Rp; Kulke, M; Pavel, M; Cwikla, J; Drozdov, I; Falconi, M; Fazio, N; Frilling, A; Jensen, R; Koopmans, K; Korse, T; Kwekkeboom, D; Maecke, H; Paganelli, G; Salazar, R; Severi, S; Strosberg, J; Prasad, V; Scarpa, A; Grossman, A; Walenkamp, A; Cives, Mauro; Virgolini, I; Kjaer, A; Modlin, Im25
Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors 1-gen-2022 Mandriani, Barbara; Pellè, Eleonora; Mannavola, Francesco; Palazzo, Antonio; Marsano, Renè Massimiliano; Ingravallo, Giuseppe; Cazzato, Gerardo; Ramello, Maria Cecilia; Porta, Camillo; Strosberg, Jonathan; Abate-Daga, Daniel; Cives, Mauro
Effect of vitaxin on hyperactive osteoclastogenesis in multiple myeloma: a preclinical study 1-gen-2010 Stucci, LUIGIA STEFANIA; DE MATTEO, Monica; Cives, Mauro; Tucci, MARCO GAETANO; Silvestris, Francesco
Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors 1-gen-2020 Cives, Mauro; Pelle', Eleonora; Strosberg, Jonathan
EPB41L5 is Associated with the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors 1-gen-2019 Saller, J.; Seydafkan, S.; Shahid, M.; Gadara, M.; Cives, M.; Eschrich, S. A.; Boulware, D.; Strosberg, J. R.; Aejaz, N.; Coppola, D.